Skip to main content
OpenTrials
Completed

NCT Number: NCT04771598

EVALUATING THE EFFICIENCY OF BREATHING EXERCISES PERFORMED BY POST-COVID TELEMEDICINE: Randomized Controlled Study

As an important non-drug intervention in the treatment of respiratory tract diseases, respiratory rehabilitation training is increasingly accepted in clinical practice. The purpose of pulmonary rehabilitation is not only to improve the physical and mental conditions of the patient, but also to help the patient return to the family and society more quickly.

In light of the widely documented lung injuries associated with COVID-19, concerns are raised regarding the assessment of lung injury in discharged patients. As an important non-drug intervention in the treatment of respiratory diseases, respiratory rehabilitation training is increasingly being accepted in clinical practice The purpose of pulmonary rehabilitation is not only to improve the physical and mental conditions of the patient, but also to help the patient return to the family and society more quickly.

The aim of the study; It is aimed to evaluate the efficiency of breathing exercise in individuals with COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tokat State Hospital

Tokat Province, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older and who received / will receive treatment with the diagnosis of COVID 19 and completed 2 months after the diagnosis of COVID 19
  • Patients who applied to the Pulmonary Diseases outpatient clinic with complaints of dyspnea
  • FEV1 / FVC <80%, FVC <80%, FEV1 <80%, FEF25-75> 50% and / or Patients with respiratory distress in daily living activities

Exclusion criteria

  • FEV 1 <50%, FEF 25-75 <50% detected oxygen saturation <85% at rest,
  • moderately severe heart failure,
  • has a disease that restricts its mobilization,
  • psychiatric illness,
  • advanced stage liver, advanced stage renal failure,
  • Myocardial infarction within 4 months
  • having a history of unstable angina
  • active infectious disease

Treatment and study plan

Breathing exercise with the phone application

Other
  • Respiratory Control:
  • Pursed Lip Breathing
  • Diaphragmatic Breathing Respiratory exercises will be instructed to the individuals forming the intervention group and participants will be asked to do 3 times a day during one month and the exercises will be done by the researchers together with the individuals by establishing a connection with the phone application (zoom, watsapp) once a week from home.

Breathing exercise

Other
  • Respiratory Control:
  • Pursed Lip Breathing
  • Diaphragmatic Breathing Breathing exercises will be explained to the control group and visual material will be given. The participants will be asked to do 3 times a day during one month. In terms of physical activity, the patient will be encouraged to participate in the program by suggesting exercises such as walking and cycling at least three times a week for 20 minutes per week

Primary outcomes

  1. 6 minute walking test

    Time frame: 1 month

    6 minute walking test

  2. FEV-1

    Time frame: 1 month

    FEV-1

  3. FVC

    Time frame: 1 month

    FVC

  4. FEV1/FVC

    Time frame: 1 month

    FEV1/FVC

  5. MVV

    Time frame: 1 month

    MVV- Maximal Voluntary Ventilation

Secondary outcomes

  1. St. George's Respiratory Questionnaire

    Time frame: 1 month

    St. George's Respiratory Questionnaire-Scores range from 0 to 100, with higher scores indicating more limitations.

Sponsors and collaborators

Lead sponsor

Tokat Gaziosmanpasa University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Feb 25, 2021
Registry last updated
Feb 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.